nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—CYP3A4—Rivastigmine—Alzheimer's disease	0.167	0.432	CbGbCtD
Paricalcitol—CYP3A4—Donepezil—Alzheimer's disease	0.133	0.345	CbGbCtD
Paricalcitol—CYP3A4—Galantamine—Alzheimer's disease	0.0859	0.223	CbGbCtD
Paricalcitol—UGT1A4—Heme degradation—HMOX1—Alzheimer's disease	0.00674	0.0555	CbGpPWpGaD
Paricalcitol—UGT1A4—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.00517	0.0426	CbGpPWpGaD
Paricalcitol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.00405	0.0334	CbGpPWpGaD
Paricalcitol—CYP24A1—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.004	0.0329	CbGpPWpGaD
Paricalcitol—UGT1A4—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.00333	0.0274	CbGpPWpGaD
Paricalcitol—Calcipotriol—MPO—Alzheimer's disease	0.00332	0.806	CrCbGaD
Paricalcitol—CYP24A1—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.00328	0.027	CbGpPWpGaD
Paricalcitol—UGT1A4—Porphyrin metabolism—HMOX1—Alzheimer's disease	0.00293	0.0241	CbGpPWpGaD
Paricalcitol—VDR—Validated transcriptional targets of TAp63 isoforms—YWHAQ—Alzheimer's disease	0.00262	0.0216	CbGpPWpGaD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—Alzheimer's disease	0.00255	0.021	CbGpPWpGaD
Paricalcitol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.00245	0.0202	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.00206	0.0169	CbGpPWpGaD
Paricalcitol—CYP24A1—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.00196	0.0161	CbGpPWpGaD
Paricalcitol—VDR—Validated transcriptional targets of TAp63 isoforms—OGG1—Alzheimer's disease	0.00184	0.0151	CbGpPWpGaD
Paricalcitol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.0018	0.0148	CbGpPWpGaD
Paricalcitol—UGT1A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.00177	0.0146	CbGpPWpGaD
Paricalcitol—CYP24A1—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.00177	0.0146	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—CYP46A1—Alzheimer's disease	0.00174	0.0144	CbGpPWpGaD
Paricalcitol—VDR—Retinoic acid receptors-mediated signaling—PRKCG—Alzheimer's disease	0.00173	0.0143	CbGpPWpGaD
Paricalcitol—CYP24A1—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.00172	0.0142	CbGpPWpGaD
Paricalcitol—CYP24A1—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.00148	0.0122	CbGpPWpGaD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—PPARG—Alzheimer's disease	0.00146	0.012	CbGpPWpGaD
Paricalcitol—CYP24A1—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.00146	0.012	CbGpPWpGaD
Paricalcitol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.00141	0.0116	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—CYP46A1—Alzheimer's disease	0.00139	0.0115	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.00138	0.0113	CbGpPWpGaD
Paricalcitol—VDR—Validated transcriptional targets of deltaNp63 isoforms—IL1A—Alzheimer's disease	0.00128	0.0105	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—TP73—Alzheimer's disease	0.00126	0.0104	CbGpPWpGaD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—BCL2—Alzheimer's disease	0.00121	0.00996	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—BAX—Alzheimer's disease	0.0012	0.00988	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors—ESR1—Alzheimer's disease	0.00118	0.00973	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.00118	0.0097	CbGpPWpGaD
Paricalcitol—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Alzheimer's disease	0.00117	0.00962	CbGpPWpGaD
Paricalcitol—VDR—Validated transcriptional targets of TAp63 isoforms—BAX—Alzheimer's disease	0.00111	0.00911	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors—PPARG—Alzheimer's disease	0.00108	0.00888	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—MAOB—Alzheimer's disease	0.00104	0.00857	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.001	0.00827	CbGpPWpGaD
Paricalcitol—CYP3A4—Tryptophan metabolism—DHCR24—Alzheimer's disease	0.000974	0.00803	CbGpPWpGaD
Paricalcitol—VDR—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—Alzheimer's disease	0.000963	0.00793	CbGpPWpGaD
Paricalcitol—Urinary tract infection—Memantine—Alzheimer's disease	0.000934	0.00191	CcSEcCtD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—ESR1—Alzheimer's disease	0.000933	0.00769	CbGpPWpGaD
Paricalcitol—Urethral disorder—Donepezil—Alzheimer's disease	0.000931	0.0019	CcSEcCtD
Paricalcitol—Cough—Galantamine—Alzheimer's disease	0.000931	0.0019	CcSEcCtD
Paricalcitol—Hypertension—Galantamine—Alzheimer's disease	0.000921	0.00188	CcSEcCtD
Paricalcitol—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000913	0.00187	CcSEcCtD
Paricalcitol—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000913	0.00187	CcSEcCtD
Paricalcitol—Chest pain—Galantamine—Alzheimer's disease	0.000908	0.00186	CcSEcCtD
Paricalcitol—Arthralgia—Galantamine—Alzheimer's disease	0.000908	0.00186	CcSEcCtD
Paricalcitol—Myalgia—Galantamine—Alzheimer's disease	0.000908	0.00186	CcSEcCtD
Paricalcitol—Epistaxis—Memantine—Alzheimer's disease	0.000906	0.00185	CcSEcCtD
Paricalcitol—Anxiety—Galantamine—Alzheimer's disease	0.000905	0.00185	CcSEcCtD
Paricalcitol—VDR—Validated transcriptional targets of deltaNp63 isoforms—GSK3B—Alzheimer's disease	0.000904	0.00745	CbGpPWpGaD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000902	0.00185	CcSEcCtD
Paricalcitol—Sinusitis—Memantine—Alzheimer's disease	0.000901	0.00184	CcSEcCtD
Paricalcitol—Sweating—Rivastigmine—Alzheimer's disease	0.000901	0.00184	CcSEcCtD
Paricalcitol—Discomfort—Galantamine—Alzheimer's disease	0.000897	0.00184	CcSEcCtD
Paricalcitol—Dry mouth—Galantamine—Alzheimer's disease	0.000888	0.00182	CcSEcCtD
Paricalcitol—Epistaxis—Rivastigmine—Alzheimer's disease	0.000886	0.00181	CcSEcCtD
Paricalcitol—Sinusitis—Rivastigmine—Alzheimer's disease	0.000881	0.0018	CcSEcCtD
Paricalcitol—Confusional state—Galantamine—Alzheimer's disease	0.000878	0.0018	CcSEcCtD
Paricalcitol—VDR—Retinoic acid receptors-mediated signaling—MAPK8—Alzheimer's disease	0.000874	0.0072	CbGpPWpGaD
Paricalcitol—Hypoaesthesia—Memantine—Alzheimer's disease	0.000858	0.00176	CcSEcCtD
Paricalcitol—Shock—Galantamine—Alzheimer's disease	0.000856	0.00175	CcSEcCtD
Paricalcitol—Pharyngitis—Memantine—Alzheimer's disease	0.000856	0.00175	CcSEcCtD
Paricalcitol—Nervous system disorder—Galantamine—Alzheimer's disease	0.000854	0.00175	CcSEcCtD
Paricalcitol—Chills—Donepezil—Alzheimer's disease	0.000852	0.00174	CcSEcCtD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—PPARG—Alzheimer's disease	0.000851	0.00701	CbGpPWpGaD
Paricalcitol—Urinary tract disorder—Memantine—Alzheimer's disease	0.000851	0.00174	CcSEcCtD
Paricalcitol—Oedema peripheral—Memantine—Alzheimer's disease	0.000849	0.00174	CcSEcCtD
Paricalcitol—Arrhythmia—Donepezil—Alzheimer's disease	0.000848	0.00174	CcSEcCtD
Paricalcitol—Connective tissue disorder—Memantine—Alzheimer's disease	0.000847	0.00173	CcSEcCtD
Paricalcitol—Skin disorder—Galantamine—Alzheimer's disease	0.000846	0.00173	CcSEcCtD
Paricalcitol—Urethral disorder—Memantine—Alzheimer's disease	0.000845	0.00173	CcSEcCtD
Paricalcitol—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000842	0.00172	CcSEcCtD
Paricalcitol—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.000839	0.00691	CbGpPWpGaD
Paricalcitol—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000839	0.00172	CcSEcCtD
Paricalcitol—Alopecia—Donepezil—Alzheimer's disease	0.000839	0.00172	CcSEcCtD
Paricalcitol—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000837	0.00171	CcSEcCtD
Paricalcitol—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000833	0.0017	CcSEcCtD
Paricalcitol—UGT1A4—Biological oxidations—MAOB—Alzheimer's disease	0.000832	0.00685	CbGpPWpGaD
Paricalcitol—Mental disorder—Donepezil—Alzheimer's disease	0.000832	0.0017	CcSEcCtD
Paricalcitol—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000831	0.0017	CcSEcCtD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—Alzheimer's disease	0.00083	0.00684	CbGpPWpGaD
Paricalcitol—Anorexia—Galantamine—Alzheimer's disease	0.00083	0.0017	CcSEcCtD
Paricalcitol—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000829	0.0017	CcSEcCtD
Paricalcitol—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000827	0.00169	CcSEcCtD
Paricalcitol—Malnutrition—Donepezil—Alzheimer's disease	0.000827	0.00169	CcSEcCtD
Paricalcitol—Hypotension—Galantamine—Alzheimer's disease	0.000813	0.00166	CcSEcCtD
Paricalcitol—Tension—Donepezil—Alzheimer's disease	0.000811	0.00166	CcSEcCtD
Paricalcitol—Dysgeusia—Donepezil—Alzheimer's disease	0.000809	0.00166	CcSEcCtD
Paricalcitol—Eye disorder—Memantine—Alzheimer's disease	0.000806	0.00165	CcSEcCtD
Paricalcitol—Nervousness—Donepezil—Alzheimer's disease	0.000803	0.00164	CcSEcCtD
Paricalcitol—Cholecalciferol—CYP2D6—Alzheimer's disease	0.000801	0.194	CrCbGaD
Paricalcitol—Cardiac disorder—Memantine—Alzheimer's disease	0.0008	0.00164	CcSEcCtD
Paricalcitol—Back pain—Donepezil—Alzheimer's disease	0.0008	0.00164	CcSEcCtD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—MEF2C—Alzheimer's disease	0.000798	0.00658	CbGpPWpGaD
Paricalcitol—Muscle spasms—Donepezil—Alzheimer's disease	0.000795	0.00163	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000793	0.00162	CcSEcCtD
Paricalcitol—CYP24A1—Biological oxidations—PTGS1—Alzheimer's disease	0.000789	0.0065	CbGpPWpGaD
Paricalcitol—Eye disorder—Rivastigmine—Alzheimer's disease	0.000788	0.00161	CcSEcCtD
Paricalcitol—Insomnia—Galantamine—Alzheimer's disease	0.000787	0.00161	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—CTSD—Alzheimer's disease	0.000787	0.00648	CbGpPWpGaD
Paricalcitol—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000783	0.0016	CcSEcCtD
Paricalcitol—Angiopathy—Memantine—Alzheimer's disease	0.000782	0.0016	CcSEcCtD
Paricalcitol—Paraesthesia—Galantamine—Alzheimer's disease	0.000782	0.0016	CcSEcCtD
Paricalcitol—Immune system disorder—Memantine—Alzheimer's disease	0.000779	0.00159	CcSEcCtD
Paricalcitol—Mediastinal disorder—Memantine—Alzheimer's disease	0.000777	0.00159	CcSEcCtD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TNF—Alzheimer's disease	0.000775	0.00639	CbGpPWpGaD
Paricalcitol—Somnolence—Galantamine—Alzheimer's disease	0.000774	0.00158	CcSEcCtD
Paricalcitol—Chills—Memantine—Alzheimer's disease	0.000774	0.00158	CcSEcCtD
Paricalcitol—CYP24A1—Biological oxidations—CYP2D6—Alzheimer's disease	0.000773	0.00637	CbGpPWpGaD
Paricalcitol—Arrhythmia—Memantine—Alzheimer's disease	0.00077	0.00158	CcSEcCtD
Paricalcitol—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000767	0.00157	CcSEcCtD
Paricalcitol—Dyspepsia—Galantamine—Alzheimer's disease	0.000766	0.00157	CcSEcCtD
Paricalcitol—Angiopathy—Rivastigmine—Alzheimer's disease	0.000765	0.00157	CcSEcCtD
Paricalcitol—Anaemia—Donepezil—Alzheimer's disease	0.000764	0.00156	CcSEcCtD
Paricalcitol—CYP24A1—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000763	0.00628	CbGpPWpGaD
Paricalcitol—Alopecia—Memantine—Alzheimer's disease	0.000762	0.00156	CcSEcCtD
Paricalcitol—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00076	0.00156	CcSEcCtD
Paricalcitol—Agitation—Donepezil—Alzheimer's disease	0.00076	0.00155	CcSEcCtD
Paricalcitol—Chills—Rivastigmine—Alzheimer's disease	0.000757	0.00155	CcSEcCtD
Paricalcitol—Decreased appetite—Galantamine—Alzheimer's disease	0.000757	0.00155	CcSEcCtD
Paricalcitol—Mental disorder—Memantine—Alzheimer's disease	0.000755	0.00155	CcSEcCtD
Paricalcitol—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000753	0.00154	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000752	0.00154	CcSEcCtD
Paricalcitol—Malnutrition—Memantine—Alzheimer's disease	0.000751	0.00154	CcSEcCtD
Paricalcitol—Fatigue—Galantamine—Alzheimer's disease	0.00075	0.00154	CcSEcCtD
Paricalcitol—Malaise—Donepezil—Alzheimer's disease	0.000745	0.00153	CcSEcCtD
Paricalcitol—Alopecia—Rivastigmine—Alzheimer's disease	0.000745	0.00153	CcSEcCtD
Paricalcitol—Constipation—Galantamine—Alzheimer's disease	0.000744	0.00152	CcSEcCtD
Paricalcitol—Vertigo—Donepezil—Alzheimer's disease	0.000743	0.00152	CcSEcCtD
Paricalcitol—Syncope—Donepezil—Alzheimer's disease	0.000741	0.00152	CcSEcCtD
Paricalcitol—Mental disorder—Rivastigmine—Alzheimer's disease	0.000739	0.00151	CcSEcCtD
Paricalcitol—Tension—Memantine—Alzheimer's disease	0.000736	0.00151	CcSEcCtD
Paricalcitol—Dysgeusia—Memantine—Alzheimer's disease	0.000735	0.0015	CcSEcCtD
Paricalcitol—Malnutrition—Rivastigmine—Alzheimer's disease	0.000734	0.0015	CcSEcCtD
Paricalcitol—Nervousness—Memantine—Alzheimer's disease	0.000729	0.00149	CcSEcCtD
Paricalcitol—Loss of consciousness—Donepezil—Alzheimer's disease	0.000727	0.00149	CcSEcCtD
Paricalcitol—Back pain—Memantine—Alzheimer's disease	0.000726	0.00149	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000726	0.00598	CbGpPWpGaD
Paricalcitol—Cough—Donepezil—Alzheimer's disease	0.000721	0.00148	CcSEcCtD
Paricalcitol—Tension—Rivastigmine—Alzheimer's disease	0.00072	0.00147	CcSEcCtD
Paricalcitol—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000719	0.00147	CcSEcCtD
Paricalcitol—Feeling abnormal—Galantamine—Alzheimer's disease	0.000717	0.00147	CcSEcCtD
Paricalcitol—Hypertension—Donepezil—Alzheimer's disease	0.000714	0.00146	CcSEcCtD
Paricalcitol—Nervousness—Rivastigmine—Alzheimer's disease	0.000713	0.00146	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000712	0.00146	CcSEcCtD
Paricalcitol—Back pain—Rivastigmine—Alzheimer's disease	0.00071	0.00145	CcSEcCtD
Paricalcitol—CYP3A4—Irinotecan Pathway—BCHE—Alzheimer's disease	0.000708	0.00583	CbGpPWpGaD
Paricalcitol—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000706	0.00144	CcSEcCtD
Paricalcitol—UGT1A4—NRF2 pathway—SLC6A4—Alzheimer's disease	0.000705	0.00581	CbGpPWpGaD
Paricalcitol—Arthralgia—Donepezil—Alzheimer's disease	0.000704	0.00144	CcSEcCtD
Paricalcitol—Chest pain—Donepezil—Alzheimer's disease	0.000704	0.00144	CcSEcCtD
Paricalcitol—Myalgia—Donepezil—Alzheimer's disease	0.000704	0.00144	CcSEcCtD
Paricalcitol—Anxiety—Donepezil—Alzheimer's disease	0.000701	0.00144	CcSEcCtD
Paricalcitol—Ill-defined disorder—Memantine—Alzheimer's disease	0.000696	0.00143	CcSEcCtD
Paricalcitol—Discomfort—Donepezil—Alzheimer's disease	0.000695	0.00142	CcSEcCtD
Paricalcitol—Anaemia—Memantine—Alzheimer's disease	0.000694	0.00142	CcSEcCtD
Paricalcitol—Agitation—Memantine—Alzheimer's disease	0.00069	0.00141	CcSEcCtD
Paricalcitol—Dry mouth—Donepezil—Alzheimer's disease	0.000688	0.00141	CcSEcCtD
Paricalcitol—Body temperature increased—Galantamine—Alzheimer's disease	0.000688	0.00141	CcSEcCtD
Paricalcitol—Abdominal pain—Galantamine—Alzheimer's disease	0.000688	0.00141	CcSEcCtD
Paricalcitol—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000681	0.00139	CcSEcCtD
Paricalcitol—Confusional state—Donepezil—Alzheimer's disease	0.00068	0.00139	CcSEcCtD
Paricalcitol—Anaemia—Rivastigmine—Alzheimer's disease	0.000679	0.00139	CcSEcCtD
Paricalcitol—Malaise—Memantine—Alzheimer's disease	0.000677	0.00139	CcSEcCtD
Paricalcitol—CYP3A4—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.000675	0.00556	CbGpPWpGaD
Paricalcitol—Agitation—Rivastigmine—Alzheimer's disease	0.000675	0.00138	CcSEcCtD
Paricalcitol—Oedema—Donepezil—Alzheimer's disease	0.000675	0.00138	CcSEcCtD
Paricalcitol—Vertigo—Memantine—Alzheimer's disease	0.000674	0.00138	CcSEcCtD
Paricalcitol—Syncope—Memantine—Alzheimer's disease	0.000673	0.00138	CcSEcCtD
Paricalcitol—Leukopenia—Memantine—Alzheimer's disease	0.000672	0.00137	CcSEcCtD
Paricalcitol—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	0.000671	0.00553	CbGpPWpGaD
Paricalcitol—Infection—Donepezil—Alzheimer's disease	0.00067	0.00137	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.00067	0.00552	CbGpPWpGaD
Paricalcitol—Shock—Donepezil—Alzheimer's disease	0.000664	0.00136	CcSEcCtD
Paricalcitol—Palpitations—Memantine—Alzheimer's disease	0.000663	0.00136	CcSEcCtD
Paricalcitol—Malaise—Rivastigmine—Alzheimer's disease	0.000662	0.00135	CcSEcCtD
Paricalcitol—Nervous system disorder—Donepezil—Alzheimer's disease	0.000662	0.00135	CcSEcCtD
Paricalcitol—Vertigo—Rivastigmine—Alzheimer's disease	0.00066	0.00135	CcSEcCtD
Paricalcitol—Loss of consciousness—Memantine—Alzheimer's disease	0.00066	0.00135	CcSEcCtD
Paricalcitol—Syncope—Rivastigmine—Alzheimer's disease	0.000658	0.00135	CcSEcCtD
Paricalcitol—Cough—Memantine—Alzheimer's disease	0.000655	0.00134	CcSEcCtD
Paricalcitol—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000652	0.00133	CcSEcCtD
Paricalcitol—Palpitations—Rivastigmine—Alzheimer's disease	0.000649	0.00133	CcSEcCtD
Paricalcitol—Hypertension—Memantine—Alzheimer's disease	0.000648	0.00133	CcSEcCtD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL1B—Alzheimer's disease	0.000646	0.00532	CbGpPWpGaD
Paricalcitol—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000645	0.00132	CcSEcCtD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—ESR1—Alzheimer's disease	0.000645	0.00531	CbGpPWpGaD
Paricalcitol—Anorexia—Donepezil—Alzheimer's disease	0.000643	0.00132	CcSEcCtD
Paricalcitol—Hypersensitivity—Galantamine—Alzheimer's disease	0.000641	0.00131	CcSEcCtD
Paricalcitol—Cough—Rivastigmine—Alzheimer's disease	0.000641	0.00131	CcSEcCtD
Paricalcitol—Myalgia—Memantine—Alzheimer's disease	0.000639	0.00131	CcSEcCtD
Paricalcitol—Chest pain—Memantine—Alzheimer's disease	0.000639	0.00131	CcSEcCtD
Paricalcitol—Arthralgia—Memantine—Alzheimer's disease	0.000639	0.00131	CcSEcCtD
Paricalcitol—Anxiety—Memantine—Alzheimer's disease	0.000637	0.0013	CcSEcCtD
Paricalcitol—Hypertension—Rivastigmine—Alzheimer's disease	0.000634	0.0013	CcSEcCtD
Paricalcitol—Discomfort—Memantine—Alzheimer's disease	0.000631	0.00129	CcSEcCtD
Paricalcitol—UGT1A4—Biological oxidations—PTGS1—Alzheimer's disease	0.00063	0.00519	CbGpPWpGaD
Paricalcitol—Hypotension—Donepezil—Alzheimer's disease	0.00063	0.00129	CcSEcCtD
Paricalcitol—Myalgia—Rivastigmine—Alzheimer's disease	0.000625	0.00128	CcSEcCtD
Paricalcitol—Chest pain—Rivastigmine—Alzheimer's disease	0.000625	0.00128	CcSEcCtD
Paricalcitol—Arthralgia—Rivastigmine—Alzheimer's disease	0.000625	0.00128	CcSEcCtD
Paricalcitol—Dry mouth—Memantine—Alzheimer's disease	0.000625	0.00128	CcSEcCtD
Paricalcitol—Asthenia—Galantamine—Alzheimer's disease	0.000625	0.00128	CcSEcCtD
Paricalcitol—Anxiety—Rivastigmine—Alzheimer's disease	0.000623	0.00127	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000621	0.00127	CcSEcCtD
Paricalcitol—UGT1A4—Biological oxidations—CYP2D6—Alzheimer's disease	0.000618	0.00509	CbGpPWpGaD
Paricalcitol—Confusional state—Memantine—Alzheimer's disease	0.000618	0.00126	CcSEcCtD
Paricalcitol—Discomfort—Rivastigmine—Alzheimer's disease	0.000618	0.00126	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000615	0.00126	CcSEcCtD
Paricalcitol—Oedema—Memantine—Alzheimer's disease	0.000613	0.00125	CcSEcCtD
Paricalcitol—Dry mouth—Rivastigmine—Alzheimer's disease	0.000611	0.00125	CcSEcCtD
Paricalcitol—Insomnia—Donepezil—Alzheimer's disease	0.00061	0.00125	CcSEcCtD
Paricalcitol—UGT1A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.00061	0.00502	CbGpPWpGaD
Paricalcitol—Infection—Memantine—Alzheimer's disease	0.000609	0.00125	CcSEcCtD
Paricalcitol—Paraesthesia—Donepezil—Alzheimer's disease	0.000606	0.00124	CcSEcCtD
Paricalcitol—Confusional state—Rivastigmine—Alzheimer's disease	0.000604	0.00124	CcSEcCtD
Paricalcitol—Shock—Memantine—Alzheimer's disease	0.000603	0.00123	CcSEcCtD
Paricalcitol—Dyspnoea—Donepezil—Alzheimer's disease	0.000601	0.00123	CcSEcCtD
Paricalcitol—Nervous system disorder—Memantine—Alzheimer's disease	0.000601	0.00123	CcSEcCtD
Paricalcitol—Somnolence—Donepezil—Alzheimer's disease	0.0006	0.00123	CcSEcCtD
Paricalcitol—Oedema—Rivastigmine—Alzheimer's disease	0.000599	0.00123	CcSEcCtD
Paricalcitol—Diarrhoea—Galantamine—Alzheimer's disease	0.000596	0.00122	CcSEcCtD
Paricalcitol—Infection—Rivastigmine—Alzheimer's disease	0.000595	0.00122	CcSEcCtD
Paricalcitol—Skin disorder—Memantine—Alzheimer's disease	0.000595	0.00122	CcSEcCtD
Paricalcitol—Dyspepsia—Donepezil—Alzheimer's disease	0.000594	0.00122	CcSEcCtD
Paricalcitol—Hyperhidrosis—Memantine—Alzheimer's disease	0.000592	0.00121	CcSEcCtD
Paricalcitol—Shock—Rivastigmine—Alzheimer's disease	0.00059	0.00121	CcSEcCtD
Paricalcitol—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000588	0.0012	CcSEcCtD
Paricalcitol—Decreased appetite—Donepezil—Alzheimer's disease	0.000586	0.0012	CcSEcCtD
Paricalcitol—Anorexia—Memantine—Alzheimer's disease	0.000584	0.00119	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000582	0.00119	CcSEcCtD
Paricalcitol—Skin disorder—Rivastigmine—Alzheimer's disease	0.000582	0.00119	CcSEcCtD
Paricalcitol—Fatigue—Donepezil—Alzheimer's disease	0.000582	0.00119	CcSEcCtD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—CREB1—Alzheimer's disease	0.00058	0.00478	CbGpPWpGaD
Paricalcitol—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000579	0.00119	CcSEcCtD
Paricalcitol—Pain—Donepezil—Alzheimer's disease	0.000577	0.00118	CcSEcCtD
Paricalcitol—Constipation—Donepezil—Alzheimer's disease	0.000577	0.00118	CcSEcCtD
Paricalcitol—Dizziness—Galantamine—Alzheimer's disease	0.000576	0.00118	CcSEcCtD
Paricalcitol—Hypotension—Memantine—Alzheimer's disease	0.000572	0.00117	CcSEcCtD
Paricalcitol—Anorexia—Rivastigmine—Alzheimer's disease	0.000571	0.00117	CcSEcCtD
Paricalcitol—CYP3A4—Xenobiotics—CYP2D6—Alzheimer's disease	0.000561	0.00462	CbGpPWpGaD
Paricalcitol—Hypotension—Rivastigmine—Alzheimer's disease	0.00056	0.00115	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000558	0.00114	CcSEcCtD
Paricalcitol—Feeling abnormal—Donepezil—Alzheimer's disease	0.000556	0.00114	CcSEcCtD
Paricalcitol—Insomnia—Memantine—Alzheimer's disease	0.000554	0.00113	CcSEcCtD
Paricalcitol—Vomiting—Galantamine—Alzheimer's disease	0.000553	0.00113	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000552	0.00113	CcSEcCtD
Paricalcitol—Paraesthesia—Memantine—Alzheimer's disease	0.00055	0.00113	CcSEcCtD
Paricalcitol—Rash—Galantamine—Alzheimer's disease	0.000549	0.00112	CcSEcCtD
Paricalcitol—Dermatitis—Galantamine—Alzheimer's disease	0.000548	0.00112	CcSEcCtD
Paricalcitol—Dyspnoea—Memantine—Alzheimer's disease	0.000546	0.00112	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000546	0.00112	CcSEcCtD
Paricalcitol—Headache—Galantamine—Alzheimer's disease	0.000545	0.00112	CcSEcCtD
Paricalcitol—Somnolence—Memantine—Alzheimer's disease	0.000545	0.00111	CcSEcCtD
Paricalcitol—Insomnia—Rivastigmine—Alzheimer's disease	0.000542	0.00111	CcSEcCtD
Paricalcitol—CYP3A4—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.00054	0.00445	CbGpPWpGaD
Paricalcitol—Dyspepsia—Memantine—Alzheimer's disease	0.000539	0.0011	CcSEcCtD
Paricalcitol—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000538	0.0011	CcSEcCtD
Paricalcitol—Urticaria—Donepezil—Alzheimer's disease	0.000536	0.0011	CcSEcCtD
Paricalcitol—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000534	0.00109	CcSEcCtD
Paricalcitol—Abdominal pain—Donepezil—Alzheimer's disease	0.000533	0.00109	CcSEcCtD
Paricalcitol—Body temperature increased—Donepezil—Alzheimer's disease	0.000533	0.00109	CcSEcCtD
Paricalcitol—Somnolence—Rivastigmine—Alzheimer's disease	0.000533	0.00109	CcSEcCtD
Paricalcitol—Decreased appetite—Memantine—Alzheimer's disease	0.000532	0.00109	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000529	0.00108	CcSEcCtD
Paricalcitol—Fatigue—Memantine—Alzheimer's disease	0.000528	0.00108	CcSEcCtD
Paricalcitol—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000527	0.00108	CcSEcCtD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000526	0.00433	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—HMOX1—Alzheimer's disease	0.000524	0.00432	CbGpPWpGaD
Paricalcitol—Constipation—Memantine—Alzheimer's disease	0.000524	0.00107	CcSEcCtD
Paricalcitol—Pain—Memantine—Alzheimer's disease	0.000524	0.00107	CcSEcCtD
Paricalcitol—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000521	0.00107	CcSEcCtD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000519	0.00427	CbGpPWpGaD
Paricalcitol—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000517	0.00106	CcSEcCtD
Paricalcitol—Nausea—Galantamine—Alzheimer's disease	0.000517	0.00106	CcSEcCtD
Paricalcitol—Fatigue—Rivastigmine—Alzheimer's disease	0.000517	0.00106	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—BAX—Alzheimer's disease	0.000516	0.00425	CbGpPWpGaD
Paricalcitol—VDR—Retinoic acid receptors-mediated signaling—AKT1—Alzheimer's disease	0.000515	0.00424	CbGpPWpGaD
Paricalcitol—Pain—Rivastigmine—Alzheimer's disease	0.000512	0.00105	CcSEcCtD
Paricalcitol—Constipation—Rivastigmine—Alzheimer's disease	0.000512	0.00105	CcSEcCtD
Paricalcitol—Feeling abnormal—Memantine—Alzheimer's disease	0.000505	0.00103	CcSEcCtD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TGFB1—Alzheimer's disease	0.000502	0.00413	CbGpPWpGaD
Paricalcitol—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000501	0.00103	CcSEcCtD
Paricalcitol—Hypersensitivity—Donepezil—Alzheimer's disease	0.000497	0.00102	CcSEcCtD
Paricalcitol—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000494	0.00101	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00049	0.001	CcSEcCtD
Paricalcitol—Urticaria—Memantine—Alzheimer's disease	0.000487	0.000996	CcSEcCtD
Paricalcitol—Abdominal pain—Memantine—Alzheimer's disease	0.000484	0.000991	CcSEcCtD
Paricalcitol—Body temperature increased—Memantine—Alzheimer's disease	0.000484	0.000991	CcSEcCtD
Paricalcitol—Asthenia—Donepezil—Alzheimer's disease	0.000484	0.000991	CcSEcCtD
Paricalcitol—Pruritus—Donepezil—Alzheimer's disease	0.000477	0.000977	CcSEcCtD
Paricalcitol—Urticaria—Rivastigmine—Alzheimer's disease	0.000476	0.000974	CcSEcCtD
Paricalcitol—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000474	0.000969	CcSEcCtD
Paricalcitol—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000474	0.000969	CcSEcCtD
Paricalcitol—UGT1A4—NRF2 pathway—AGER—Alzheimer's disease	0.000471	0.00388	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TNF—Alzheimer's disease	0.000468	0.00386	CbGpPWpGaD
Paricalcitol—Diarrhoea—Donepezil—Alzheimer's disease	0.000462	0.000945	CcSEcCtD
Paricalcitol—Hypersensitivity—Memantine—Alzheimer's disease	0.000451	0.000924	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—DHCR24—Alzheimer's disease	0.000447	0.00368	CbGpPWpGaD
Paricalcitol—Dizziness—Donepezil—Alzheimer's disease	0.000446	0.000913	CcSEcCtD
Paricalcitol—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000441	0.000903	CcSEcCtD
Paricalcitol—Asthenia—Memantine—Alzheimer's disease	0.000439	0.000899	CcSEcCtD
Paricalcitol—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	0.000437	0.0036	CbGpPWpGaD
Paricalcitol—Pruritus—Memantine—Alzheimer's disease	0.000433	0.000887	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—CAV1—Alzheimer's disease	0.000432	0.00356	CbGpPWpGaD
Paricalcitol—Asthenia—Rivastigmine—Alzheimer's disease	0.00043	0.00088	CcSEcCtD
Paricalcitol—Vomiting—Donepezil—Alzheimer's disease	0.000429	0.000878	CcSEcCtD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000426	0.00351	CbGpPWpGaD
Paricalcitol—Rash—Donepezil—Alzheimer's disease	0.000425	0.00087	CcSEcCtD
Paricalcitol—Dermatitis—Donepezil—Alzheimer's disease	0.000425	0.00087	CcSEcCtD
Paricalcitol—Pruritus—Rivastigmine—Alzheimer's disease	0.000424	0.000868	CcSEcCtD
Paricalcitol—Headache—Donepezil—Alzheimer's disease	0.000423	0.000865	CcSEcCtD
Paricalcitol—Diarrhoea—Memantine—Alzheimer's disease	0.000419	0.000858	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.000417	0.00343	CbGpPWpGaD
Paricalcitol—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00041	0.000839	CcSEcCtD
Paricalcitol—VDR—Gene Expression—PHF1—Alzheimer's disease	0.00041	0.00337	CbGpPWpGaD
Paricalcitol—Dizziness—Memantine—Alzheimer's disease	0.000405	0.000829	CcSEcCtD
Paricalcitol—Nausea—Donepezil—Alzheimer's disease	0.000401	0.00082	CcSEcCtD
Paricalcitol—Dizziness—Rivastigmine—Alzheimer's disease	0.000396	0.000811	CcSEcCtD
Paricalcitol—Vomiting—Memantine—Alzheimer's disease	0.000389	0.000797	CcSEcCtD
Paricalcitol—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000388	0.0032	CbGpPWpGaD
Paricalcitol—Rash—Memantine—Alzheimer's disease	0.000386	0.00079	CcSEcCtD
Paricalcitol—Dermatitis—Memantine—Alzheimer's disease	0.000386	0.00079	CcSEcCtD
Paricalcitol—Headache—Memantine—Alzheimer's disease	0.000384	0.000785	CcSEcCtD
Paricalcitol—Vomiting—Rivastigmine—Alzheimer's disease	0.000381	0.00078	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CA4—Alzheimer's disease	0.00038	0.00313	CbGpPWpGaD
Paricalcitol—Rash—Rivastigmine—Alzheimer's disease	0.000378	0.000773	CcSEcCtD
Paricalcitol—Dermatitis—Rivastigmine—Alzheimer's disease	0.000377	0.000772	CcSEcCtD
Paricalcitol—Headache—Rivastigmine—Alzheimer's disease	0.000375	0.000768	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.000372	0.00306	CbGpPWpGaD
Paricalcitol—Nausea—Memantine—Alzheimer's disease	0.000364	0.000745	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—GAPDHS—Alzheimer's disease	0.000357	0.00294	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—DHCR24—Alzheimer's disease	0.000357	0.00294	CbGpPWpGaD
Paricalcitol—Nausea—Rivastigmine—Alzheimer's disease	0.000356	0.000728	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—ATP5A1—Alzheimer's disease	0.000339	0.00279	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PLD3—Alzheimer's disease	0.000323	0.00266	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.000323	0.00266	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.000319	0.00263	CbGpPWpGaD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000318	0.00262	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—BCL2—Alzheimer's disease	0.000314	0.00259	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—HSD17B10—Alzheimer's disease	0.00031	0.00255	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CA4—Alzheimer's disease	0.000304	0.0025	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.000303	0.00249	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CYP46A1—Alzheimer's disease	0.000298	0.00246	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ND1—Alzheimer's disease	0.000288	0.00237	CbGpPWpGaD
Paricalcitol—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000288	0.00237	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GAPDHS—Alzheimer's disease	0.000286	0.00235	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.000282	0.00232	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ATP5A1—Alzheimer's disease	0.000271	0.00223	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—TFAM—Alzheimer's disease	0.000264	0.00217	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PLD3—Alzheimer's disease	0.000258	0.00213	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.000258	0.00212	CbGpPWpGaD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000254	0.00209	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HSD17B10—Alzheimer's disease	0.000248	0.00204	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP46A1—Alzheimer's disease	0.000238	0.00196	CbGpPWpGaD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000233	0.00192	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	0.000233	0.00192	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ND1—Alzheimer's disease	0.00023	0.0019	CbGpPWpGaD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.00023	0.00189	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	0.000226	0.00186	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000223	0.00184	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	0.000222	0.00183	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	0.000202	0.00166	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—TGFB1—Alzheimer's disease	0.000199	0.00164	CbGpPWpGaD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000193	0.00159	CbGpPWpGaD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000189	0.00156	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—TPI1—Alzheimer's disease	0.000186	0.00153	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CHAT—Alzheimer's disease	0.000186	0.00153	CbGpPWpGaD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000182	0.0015	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—MAOB—Alzheimer's disease	0.000178	0.00147	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—TP53—Alzheimer's disease	0.000178	0.00146	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GAPDH—Alzheimer's disease	0.000171	0.00141	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	0.000169	0.0014	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	0.000168	0.00138	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—A2M—Alzheimer's disease	0.000165	0.00136	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—ESR1—Alzheimer's disease	0.000161	0.00133	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—EIF2S1—Alzheimer's disease	0.000159	0.00131	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	0.000156	0.00128	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—TPI1—Alzheimer's disease	0.000148	0.00122	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CHAT—Alzheimer's disease	0.000148	0.00122	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	0.000148	0.00122	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—PPARG—Alzheimer's disease	0.000147	0.00121	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ACHE—Alzheimer's disease	0.000144	0.00119	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—MAOB—Alzheimer's disease	0.000142	0.00117	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—INPP5D—Alzheimer's disease	0.000142	0.00117	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GAPDH—Alzheimer's disease	0.000137	0.00113	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	0.000135	0.00111	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PTGS1—Alzheimer's disease	0.000135	0.00111	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ENO1—Alzheimer's disease	0.000135	0.00111	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—A2M—Alzheimer's disease	0.000132	0.00109	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CYP2D6—Alzheimer's disease	0.000132	0.00109	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—BCHE—Alzheimer's disease	0.000125	0.00103	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PLCB1—Alzheimer's disease	0.000118	0.000975	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	0.000116	0.000956	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ACHE—Alzheimer's disease	0.000115	0.000948	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ABCA1—Alzheimer's disease	0.000115	0.000945	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—INPP5D—Alzheimer's disease	0.000114	0.000937	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PTGS1—Alzheimer's disease	0.000108	0.000888	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ENO1—Alzheimer's disease	0.000108	0.000888	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP2D6—Alzheimer's disease	0.000106	0.000871	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	0.000102	0.000843	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	0.0001	0.000827	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—BCHE—Alzheimer's disease	0.0001	0.000826	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	9.9e-05	0.000816	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PPARGC1A—Alzheimer's disease	9.88e-05	0.000814	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—HMOX1—Alzheimer's disease	9.84e-05	0.000811	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PLCB1—Alzheimer's disease	9.46e-05	0.000779	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ABCA1—Alzheimer's disease	9.17e-05	0.000755	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—LPL—Alzheimer's disease	9e-05	0.000741	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—MTHFR—Alzheimer's disease	8.1e-05	0.000667	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PPARGC1A—Alzheimer's disease	7.9e-05	0.000651	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HMOX1—Alzheimer's disease	7.87e-05	0.000648	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—ESR1—Alzheimer's disease	7.76e-05	0.000639	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CALM1—Alzheimer's disease	7.57e-05	0.000624	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—APOE—Alzheimer's disease	7.54e-05	0.000621	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—NOTCH1—Alzheimer's disease	7.5e-05	0.000618	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CAV1—Alzheimer's disease	7.47e-05	0.000616	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—LPL—Alzheimer's disease	7.19e-05	0.000593	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—PPARG—Alzheimer's disease	7.08e-05	0.000583	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PPARG—Alzheimer's disease	6.57e-05	0.000541	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—MTHFR—Alzheimer's disease	6.48e-05	0.000534	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—INS—Alzheimer's disease	6.44e-05	0.000531	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CALM1—Alzheimer's disease	6.05e-05	0.000499	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—APOE—Alzheimer's disease	6.03e-05	0.000497	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CAV1—Alzheimer's disease	5.97e-05	0.000492	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	5.8e-05	0.000478	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NOS3—Alzheimer's disease	5.65e-05	0.000466	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PPARG—Alzheimer's disease	5.25e-05	0.000433	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PTGS2—Alzheimer's disease	5.17e-05	0.000426	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—INS—Alzheimer's disease	5.15e-05	0.000424	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CA4—Alzheimer's disease	4.93e-05	0.000406	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	4.64e-05	0.000382	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NOS3—Alzheimer's disease	4.52e-05	0.000372	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	4.4e-05	0.000362	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PLD3—Alzheimer's disease	4.19e-05	0.000346	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PTGS2—Alzheimer's disease	4.13e-05	0.00034	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	4.02e-05	0.000331	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	3.87e-05	0.000319	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ND1—Alzheimer's disease	3.74e-05	0.000308	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—AKT1—Alzheimer's disease	2.8e-05	0.000231	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—AKT1—Alzheimer's disease	2.6e-05	0.000214	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—TPI1—Alzheimer's disease	2.41e-05	0.000198	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CHAT—Alzheimer's disease	2.41e-05	0.000198	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—MAOB—Alzheimer's disease	2.31e-05	0.00019	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	2.22e-05	0.000183	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—A2M—Alzheimer's disease	2.15e-05	0.000177	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—AKT1—Alzheimer's disease	2.08e-05	0.000171	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.87e-05	0.000154	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.85e-05	0.000152	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.75e-05	0.000144	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.75e-05	0.000144	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.72e-05	0.000141	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.63e-05	0.000134	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.54e-05	0.000126	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.49e-05	0.000123	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.28e-05	0.000106	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.28e-05	0.000105	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.17e-05	9.62e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.05e-05	8.66e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CALM1—Alzheimer's disease	9.82e-06	8.09e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APOE—Alzheimer's disease	9.79e-06	8.06e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CAV1—Alzheimer's disease	9.7e-06	7.99e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PPARG—Alzheimer's disease	8.53e-06	7.02e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—INS—Alzheimer's disease	8.36e-06	6.89e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NOS3—Alzheimer's disease	7.33e-06	6.04e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	6.71e-06	5.53e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.37e-06	2.78e-05	CbGpPWpGaD
